Поисковый запрос: (<.>S=РАСБУРИКАЗА<.>) |
Общее количество найденных документов : 26
Показаны документы с 1 по 20
|
|
1.
| Browning Linda A. Hemolysis and methemoglobinemia secondary to rasburicase administration // Ann. Pharmacother., 2005. Vol. 39, N 11.-С.1932-1935
|
2.
| de Bont J.M. Management of hyperuricemia with Rasburicase review // Nucleosides , Nucleotides and Nucl. Acids, 2004. Vol. 23, N 8-9.-С.1431-1440
|
3.
| de Bont J.M. Management of hyperuricemia with Rasburicase review // Nucleosides , Nucleotides and Nucl. Acids, 2004. Vol. 23, N 8-9.-С.1431-1440
|
4.
| Goldman Stanton C. Recombinant urate oxidase (Rasburicase) and IV allopurinol for hyperuricemia in patients with acute tumor Lysis syndrome (ATLS) // Cancer Invest., 2003. Vol. 21, прил. 1.-С.93-94
|
5.
| Goldman Stanton C. Recombinant urate oxidase (Rasburicase) and IV allopurinol for hyperuricemia in patients with acute tumor Lysis syndrome (ATLS) // Cancer Invest., 2003. Vol. 21, прил. 1.-С.93-94
|
6.
| Hoffmeister Rasburicase. Rekombinante Uratoxidase in der Therapie und Prophylaxe des Tumorlysesyndroms // Arzneimitteltherapie, 2002. Vol. 20, N 3.-С.65-67
|
7.
| Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study // Eur. Rev. Med. and Parmacol. Sci., 2007. Vol. 11, N 3.-С.179-184
|
8.
| Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia // Int. J. Clin. Pharm., 2011. Vol. 33, N 1.-С.58-60
|
9.
| Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia // Int. J. Clin. Pharm., 2011. Vol. 33, N 1.-С.58-60
|
10.
| Prophylaxe und differenzielle Therapie des Tumorlysesyndroms // DMW: Dtsch. med. Wochenschr., 2004. Vol. 129, N 25-26.-С.1440-1445
|
11.
| Prophylaxe und differenzielle Therapie des Tumorlysesyndroms // DMW: Dtsch. med. Wochenschr., 2004. Vol. 129, N 25-26.-С.1440-1445
|
12.
| Rasburicase for the management of tumor lysis syndrome in neonates // Ann. Pharmacother., 2006. Vol. 40, N 7-8.-С.1445-1450
|
13.
| Rasburicase for the management of tumor lysis syndrome in neonates // Ann. Pharmacother., 2006. Vol. 40, N 7-8.-С.1445-1450
|
14.
| Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy // Pharmacotherapy, 2006. Vol. 26, N 2.-С.242-247
|
15.
| Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy // Pharmacotherapy, 2006. Vol. 26, N 2.-С.242-247
|
16.
| Reeves David J. Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer // Pharmacotherapy, 2008. Vol. 28, N 6.-С.685-690
|
17.
| Reeves David J. Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer // Pharmacotherapy, 2008. Vol. 28, N 6.-С.685-690
|
18.
| Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults // Pharmacotherapy, 2006. Vol. 26, N 6.-С.806-812
|
19.
| Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults // Pharmacotherapy, 2006. Vol. 26, N 6.-С.806-812
|
20.
| Sood Amy R. Clarifying the role of rasburicase in tumor Lysis syndrome // Pharmacotherapy, 2007. Vol. 27, N 1.-С.111-121
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"